487 related articles for article (PubMed ID: 311589)
21. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
22. Non-Hodgkin's lymphomas of the lung. A study of 19 cases emphasizing the utility of frozen section immunologic studies in differential diagnosis.
Weiss LM; Yousem SA; Warnke RA
Am J Surg Pathol; 1985 Jul; 9(7):480-90. PubMed ID: 3879107
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic expression of non-Hodgkin's lymphomas in China.
Xu LZ; Tu LY; Liu YF; Hsu SM; Qiu BS; Li ZX
J Natl Cancer Inst; 1984 Sep; 73(3):635-8. PubMed ID: 6236322
[TBL] [Abstract][Full Text] [Related]
24. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
Stein H
Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
[TBL] [Abstract][Full Text] [Related]
25. The immunologic approach to the pathology of malignant lymphomas.
Lukes RJ
Am J Clin Pathol; 1979 Oct; 72(4 Suppl):657-69. PubMed ID: 386777
[TBL] [Abstract][Full Text] [Related]
26. Membrane receptor sites for the identification of lymphoreticular cells in benign and malignant conditions.
Jaffe ES; Shevach EM; Sussman EH; Frank M; Green I; Berard CW
Br J Cancer Suppl; 1975 Mar; 2():107-20. PubMed ID: 1081000
[TBL] [Abstract][Full Text] [Related]
27. Clinical and hematological heterogeneity of T-cell derived lymphoproliferative diseases.
Brouet JC; Flandrin G
Bull Cancer; 1977; 64(2):267-74. PubMed ID: 143976
[TBL] [Abstract][Full Text] [Related]
28. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.
Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH
Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674
[TBL] [Abstract][Full Text] [Related]
29. Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphomas. Correlation with clinical features.
Cossman J; Jaffe ES; Fisher RI
Cancer; 1984 Oct; 54(7):1310-7. PubMed ID: 6380700
[TBL] [Abstract][Full Text] [Related]
30. Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas.
Nanba K; Jaffe ES; Braylan RC; Soban EJ; Berard CW
Am J Clin Pathol; 1977 Nov; 68(5):535-42. PubMed ID: 335871
[TBL] [Abstract][Full Text] [Related]
31. Immunologic aspects and pathology of the malignant lymphomas.
Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
[TBL] [Abstract][Full Text] [Related]
32. Terminal deoxynucleotidyl transferase activity in malignant lymphomas.
Donlon JA; Jaffe ES; Braylan RC
N Engl J Med; 1977 Sep; 297(9):461-4. PubMed ID: 301987
[TBL] [Abstract][Full Text] [Related]
33. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
[TBL] [Abstract][Full Text] [Related]
34. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
[TBL] [Abstract][Full Text] [Related]
35. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
[TBL] [Abstract][Full Text] [Related]
36. Predictability of immunologic phenotype of malignant lymphomas by conventional morphology: a study of 60 cases.
Frizzera G; Gajl-Peczalska KJ; Bloomfield CD; Kersey JH
Cancer; 1979 Apr; 43(4):1216-24. PubMed ID: 376087
[TBL] [Abstract][Full Text] [Related]
37. Malignant lymphomas--a conceptual understanding of morphologic diversity. A review.
Mann RB; Jaffe ES; Berard CW
Am J Pathol; 1979 Jan; 94(1):105-92. PubMed ID: 367172
[No Abstract] [Full Text] [Related]
38. Immunologic characterization and ultrastructural correlations for 125 cases of B- and T-cell leukemias: studies of chronic and acute lymphocytic, prolymphocytic, lymphosarcoma cell and hairy cell leukemia, Sézary's syndrome, and other lymphoid leukemias.
Said JW; Pinkus GS
Cancer; 1981 Dec; 48(12):2630-42. PubMed ID: 6975649
[TBL] [Abstract][Full Text] [Related]
39. Malignant lymphomas as tumours of the immune system.
Berard CW; Cossman J; Jaffe ES
Br J Cancer; 1980 Jul; 42(1):1-20. PubMed ID: 7000112
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibody studies in non-Hodgkin's lymphoma.
Aisenberg AC; Wilkes BM; Harris NL
Blood; 1983 Mar; 61(3):469-75. PubMed ID: 6824784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
